Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | NOVT | GBCI |
|---|---|---|
| Price | $150.61 | $43.75 |
| Change today | ▲ 0.90% | ▼ 0.36% |
| Market cap | $5.70B | $5.70B |
| Return, 3 months | +1.9% | -15.8% |
| Return, year to date | +26.6% | +0.7% |
| Return, 1 year | +44.4% | -7.2% |
| P/E (TTM) | 95.3 | 17.9 |
| P/B | 3.5 | 1.3 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | 3.77% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 59 | 36 |
| 30-day volatility | 38.5% | 15.6% |
| Max drawdown, 1 year | -27.0% | -20.7% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
